CareDx/CDNA

$8.53

-6.67%
-
1D1W1MYTD1YMAX

About CareDx

CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The Company’s product portfolio includes AlloSeq Tx, QTYPE, Olerup SSP, AlloSeq HCT and AlloSeq cfDNA. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Ticker

CDNA

Sector

Healthcare

Trading on

NASDAQ

Industry

Healthcare Facilities

CEO

Alexander Johnson

Employees

635

Headquarters

Brisbane, United States

CareDx Metrics

BasicAdvanced
$441.67M
Market cap
-
P/E ratio
-$3.55
EPS
1.48
Beta
-
Dividend rate
$441.67M
1.47677
$12.93
$4.80
905.27K
4.018
3.769
-37.69%
-54.98%
-44.47%
1.576
1.681
2.52
-12.89%
-147.14%
13.41%

What the Analysts think about CareDx

Analyst Ratings

Majority rating from 7 analysts.
Buy

Price Targets

Average projection from 5 analysts.
45.37% upside
High $15.00
Low $10.00
$8.53
Current price
$12.40
Average price target

CareDx Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-180.15% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$65.5M
-2.38%
Net income
$-118M
404.27%
Profit margin
-180.15%
416.63%

CareDx Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 36.19%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.11
-$0.18
-$0.18
-$0.17
-
Expected
-$0.11
-$0.31
-$0.40
-$0.27
-$0.19
Surprise
1.85%
-41.94%
-54.48%
-36.19%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for CareDx stock?

CareDx (CDNA) has a market cap of $441.67M as of April 15, 2024.

What is the P/E ratio for CareDx stock?

The price to earnings (P/E) ratio for CareDx (CDNA) stock is 0 as of April 15, 2024.

Does CareDx stock pay dividends?

No, CareDx (CDNA) stock does not pay dividends to its shareholders as of April 15, 2024.

When is the next CareDx dividend payment date?

CareDx (CDNA) stock does not pay dividends to its shareholders.

What is the beta indicator for CareDx?

CareDx (CDNA) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the CareDx stock price target?

The target price for CareDx (CDNA) stock is $12.4, which is 45.37% above the current price of $8.53. This is an average based on projections from 5 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell CareDx stock

Buy or sell CareDx stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing